DFCM
AVXL icon

Dark Forest Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Dark Forest Capital Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,530
Closed -$75.5K – 507
2023
Q3 		$75.5K Buy
+11,530
New +$91.8K 0.01% 1055
2023
Q2 		– Sell
-601
Closed -$5.15K – 1043
2023
Q1 		$5.15K Buy
+601
New +$6K ﹤0.01% 1067
2022
Q1 		– Sell
-6,189
Closed -$107K – 1276
2021
Q4 		$107K Buy
+6,189
New +$118K 0.04% 330

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Dark Forest Capital Management's AVXL Position: Q4 2023 in Review

Dark Forest Capital Management sold out of Anavex Life Sciences (AVXL) in Q4 2023, closing a stake of 11,530 shares — an estimated $75.5K sold.

Dark Forest Capital Management first reported a position in AVXL in Q4 2021 and held it in 3 quarters. The position peaked at $107K in Q4 2021. 153 funds tracked by Wall St. Rank hold AVXL as of Q4 2023.

  • Dark Forest Capital Management reported no remaining Anavex Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 11,530 Anavex Life Sciences shares in Q4 2023, an estimated $75.5K.
  • Dark Forest Capital Management first reported a position in Anavex Life Sciences in Q4 2021 and held it in 3 quarters.
  • Dark Forest Capital Management's Anavex Life Sciences position peaked at $107K in Q4 2021.
  • 153 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2023.

Based on Dark Forest Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.